Plunkett Research Online: HemaCare Corporation

HEMACARE CORPORATION (HEMA:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

HemaCare Corporation provides human blood products and services in support of the field of immune therapy, including stem cell therapy. The firm is engaged in blood, tissue and cell collection, processing and storage, with a robust donor recruitment and management system which supports and extensiv.....



HemaCare Corporation
Ticker: HEMA
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 877-310-0717
Fax: 818-251-5300
Address: 15350 Sherman Way
Suite 423
Van Nuys, CA 91406 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Blood and Organ Banks
Blood Products
Stem-Cell Collection
Therapeutics
Temporary Equipment & Staffing
ContactsDescription
Peter van der WalCEO/Director/President
Lisa BacerraCFO/Chief Accounting Officer
See More
HemaCare Corporation provides human blood products and services in support of the field of immune therapy, including stem cell therapy. The firm is engaged in blood, tissue and cell collection, processing and storage, with a robust donor recruitment and management system which supports and extensiv.....See More See More

Auditor: Rose, Snyder & Jacobs LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201120102009
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: